AUPH

Aurinia Pharmaceuticals Inc.

Insider Trades

ActorHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Tang KevinDirector, 10 Percent Owner, Officer: Chief Executive Officer
--206k shares
BuyJun 2, 2026
$3.1M206k shares
$15.28
$15.54
Tang KevinDirector, 10 Percent Owner, Officer: Chief Executive Officer
--10k shares
OtherJun 2, 2026
$150.0K10k shares
$15.00
$15.54
Tang KevinDirector, 10 Percent Owner, Officer: Chief Executive Officer
--343.5k shares
BuyJun 1, 2026
$5.2M343.5k shares
$15.28
$15.54
Tang KevinDirector, 10 Percent Owner, Officer: Chief Executive Officer
--99 shares
BuyJun 1, 2026
$1.5K99 shares
$15.34
$15.54
Tang KevinDirector, 10 Percent Owner, Officer: Chief Executive Officer
--262.7k shares
BuyMay 29, 2026
$4.0M262.7k shares
$15.31
$15.54
Tang KevinDirector, 10 Percent Owner, Officer: Chief Executive Officer
--2.3k shares
BuyMay 29, 2026
$35.3K2.3k shares
$15.35
$15.54

News

fool.comAurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Millionfool.comJun 7seekingalpha.comAurinia: Cash-Generating Today, Pipeline-Driven Tomorrowseekingalpha.comJun 4businesswire.comLUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Deathbusinesswire.comJun 4seekingalpha.comAurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call Prepared Remarks Transcriptseekingalpha.comJun 3feeds.newsfilecorp.comAurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciencesfeeds.newsfilecorp.comMay 19